The carcinogenicity of opium consumption: a systematic review and meta-analysis
- PMID: 36773182
- PMCID: PMC10082119
- DOI: 10.1007/s10654-023-00969-7
The carcinogenicity of opium consumption: a systematic review and meta-analysis
Abstract
The carcinogenicity of opium consumption was recently evaluated by a Working Group convened by the International Agency for Research on Cancer (IARC). We supplement the recent IARC evaluation by conducting an extended systematic review as well as a quantitative meta-analytic assessment of the role of opium consumption and risk for selected cancers, evaluating in detail various aspects of study quality on meta-analytic findings. We searched the published literature to identify all relevant studies on opium consumption and risk of selected cancers in humans through 31 October, 2022. Meta-relative risks (mRRs) and associated 95% confidence intervals (CIs) were estimated using random-effects models for studies of cancer of the urinary bladder, larynx, lung, oesophagus, pancreas, and stomach. Heterogeneity among studies was assessed using the I2 statistic. We assessed study quality and conducted sensitivity analyses to evaluate the impact of potential reverse causation, protopathic bias, selection bias, information bias, and confounding. In total, 2 prospective cohort studies and 33 case-control studies were included. The overall pooled mRR estimated for 'ever or regular' versus 'never' use of opium ranged from 1.50 (95% CI 1.13-1.99, I2 = 0%, 6 studies) for oesophageal cancer to 7.97 (95% CI 4.79-13.3, I2 = 62%, 7 studies) for laryngeal cancer. Analyses of cumulative opium exposure suggested greater risk of cancer associated with higher opium consumption. Findings were robust in sensitivity analyses excluding studies prone to potential methodological sources of biases and confounding. Findings support an adverse association between opium consumption and cancers of the urinary bladder, larynx, lung, oesophagus, pancreas and stomach.
Keywords: Cancer; Case–control study; Cohort study; Meta-analysis; Opium.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
The International Agency for Research on Cancer and e-cigarette carcinogenicity: time for an evaluation.Eur J Epidemiol. 2023 Apr;38(4):391. doi: 10.1007/s10654-023-00993-7. Epub 2023 Mar 24. Eur J Epidemiol. 2023. PMID: 36961667 No abstract available.
References
-
- World Drug Report (United Nations publication, Sales No. E.21.XI.8). GLOBAL OVERVIEW: DRUG DEMAND DRUG SUPPLY [Internet]. 2021. Available from: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_2.pdf
-
- IARC Opium consumption. IARC monogr identif carcinog hazards hum. 2021;126:1–253.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
